Australia is closely watching the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor medication , representing a significant advance in obesity treatment . Early clinical trials have demonstrated https://katrinadixw961669.educationalimpactblog.com/65422233/new-treatment-in-australia-a-promising-hope-for-weight-loss